$100M–$500M

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm. The firm focuses on helping growing health care companies achieve their full potential while improving global health care. They manage capital in both private and public equity funds, investing across all sectors of the health care industry, including biopharmaceutical services, health care services, and medical devices. Great Point Partners is known for its proactive and proprietary approach to sourcing investments and has provided growth equity, recapitalization, and management buyout financing to more than 200 health care companies.

Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.

Sofinnova is a leading healthcare investment firm with a focus on life sciences, particularly therapeutic drugs. Founded in 1976, the firm has a strong track record of investing in transformative therapies, guiding companies from drug development through regulatory processes to IPOs. With approximately $3.3 billion in assets under management, Sofinnova partners with entrepreneurs to improve patient lives through science, leveraging deep industry knowledge and extensive experience in both private and public equity markets.

Revelation Partners is a healthcare-focused investment firm that provides liquidity and capital solutions to healthcare investors, companies, and funds. With over $1.5 billion in assets under management, the firm specializes in flexible capital solutions, shareholder liquidity, and fund manager solutions. Revelation Partners actively partners with management teams to scale rapidly growing healthcare companies and offers customized solutions to align shareholders and provide liquidity.

Fannin Innovation Studio is dedicated to developing early-stage pharmaceutical and medical device assets that address vital unmet medical needs. The firm primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators, particularly in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies through preclinical work and engineering up through early clinical trials, aiming to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.

Keiretsu Forum is a global investment community of accredited private equity angel investors, venture capitalists, and corporate/institutional investors. Founded in 2000 by Randy Williams in the San Francisco East Bay, it has grown into a worldwide network with 53 chapters across 4 continents. The forum is renowned for its high-quality, diverse investment opportunities and is ranked as one of the most active venture investors in the USA. Keiretsu Forum emphasizes a holistic approach to investment, fostering interlocking relationships with partners and key resources to offer top-tier deal flow and investment opportunities. The community is also actively involved in social and charitable activities, enhancing its global network of capital, resources, and deal flow.

SternAegis Ventures is the Private Equity Investment Banking Division of Aegis Capital Corp. The firm partners with entrepreneurs and early-stage companies to bring ideas to life, aiming to create brands with long-term investment value. SternAegis adds value through its expertise in capital formation and the introduction of strategic relationships.

Eurazeo is a leading private asset manager in Europe, leveraging a diversified fund offering and a unique network to identify high growth potential companies. The firm is committed to building European champions with global ambitions, focusing on mid-market and growth segments. Eurazeo integrates ESG support into its strategy, aiming to invest in companies that resolve environmental, social, and societal issues, with a goal of achieving net zero carbon by 2040.

MBX Capital is a venture capital firm dedicated to investing in startups that address the root causes of environmental health and healthcare infrastructure challenges. Their mission is to support companies that are tackling the fundamental reasons behind why people get sick, with a focus on improving human health through innovative solutions. MBX Capital is committed to backing leaders who are working to clean up the environment, replace hazardous chemicals, and develop new medicines and diagnostics, while also adapting healthcare infrastructure to meet the rising burden of disease.

Forbion is a leading venture capital firm dedicated to building life sciences companies that transform people's lives. The firm collaborates closely with scientists, entrepreneurs, and academic institutions to empower groundbreaking ideas and foster healthcare innovation. With a focus on sustainable and responsible development, Forbion aims to positively impact the health and well-being of patients worldwide.

Athyrium Capital Management is a specialized asset management company founded in 2008, focusing on investment opportunities in the healthcare and life sciences sectors. With over $5 billion in capital invested across 85+ portfolio companies, Athyrium leverages its extensive experience in public and private equity, fixed income, royalties, and structured securities to support commercial-stage companies with compelling products and differentiated services. The firm is dedicated to providing flexible financing solutions to achieve growth objectives, backed by a global network of innovators and experts.

Fountain Healthcare Partners is a venture fund that provides risk capital and expertise to ambitious entrepreneurs building outstanding life sciences companies. The firm focuses on a limited number of active portfolio companies to provide more than just capital, offering strategic guidance and support. With a strong presence in both Europe and the United States, Fountain Healthcare Partners invests primarily in the life sciences sector, including specialty pharma, biopharmaceuticals, medical devices, and diagnostics. The firm is committed to responsible investment and aims to facilitate partnerships and build international networks to help its portfolio companies succeed.